213 related articles for article (PubMed ID: 2502083)
1. [Effectiveness of tobramycin and immunologic preparations in experimental Pseudomonas infection].
Minukhin VV; Tsyganenko AIa
Antibiot Khimioter; 1989 Apr; 34(4):282-6. PubMed ID: 2502083
[TBL] [Abstract][Full Text] [Related]
2. [Experimental basis for the combined use of tobramycin and immune preparations for treating acute Pseudomonas aeruginosa infections].
Minukhin VV; Tsyganenko VIa
Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):42-5. PubMed ID: 3094301
[TBL] [Abstract][Full Text] [Related]
3. [Dynamics of the contamination of mice during the treatment of burn sepsis due to Pseudomonas aeruginosa using tobramycin alone or combined with active and passive immunization].
Minukhin VV; Tsyganenko AIa
Zh Mikrobiol Epidemiol Immunobiol; 1986 Sep; (9):90-2. PubMed ID: 3098009
[TBL] [Abstract][Full Text] [Related]
4. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
Moroz AF; Kharitonova AM; Chanturiia TsK
Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa infection: pathogenesis and therapy.
Pennington JE
Compr Ther; 1979 May; 5(5):14-22. PubMed ID: 110508
[No Abstract] [Full Text] [Related]
6. [Treatment of an infection due to the intraperitoneal inoculation of mice with Pseudomonas aeruginosa with tobramycin and hyperimmune Pseudomonas aeruginosa plasma used per se and in combination].
Minukhin VV; Tsyganenko AIa
Antibiot Med Biotekhnol; 1986 Oct; 31(10):778-81. PubMed ID: 3098161
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of a polyvalent corpuscular Pseudomonas aeruginosa vaccine, antibiotics and their combinations in experimental chronic Pseudomonas aeruginosa infection].
Vetkova LG; Antsiferova NG; Radkevich SA; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1985 Mar; (3):51-6. PubMed ID: 3922187
[TBL] [Abstract][Full Text] [Related]
8. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
[TBL] [Abstract][Full Text] [Related]
9. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
10. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
[No Abstract] [Full Text] [Related]
11. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
Roe EA; Jones RJ
Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
[TBL] [Abstract][Full Text] [Related]
12. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
[TBL] [Abstract][Full Text] [Related]
13. The immunoprophylaxis and immunotherapy of Pseudomonas infections in burns with polyvalent Pseudomonas aeruginosa corpuscular vaccine.
Ionescu A; Meitert E; Vasiliu S; Meitert T; Milicescu S; Sima F; Savulian C
Arch Roum Pathol Exp Microbiol; 1979; 38(3-4):317-30. PubMed ID: 122594
[No Abstract] [Full Text] [Related]
14. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: immunization using divalent flagella preparations.
Holder IA; Naglich JG
J Trauma; 1986 Feb; 26(2):118-22. PubMed ID: 2418208
[TBL] [Abstract][Full Text] [Related]
15. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
Hunt JL; Purdue GF
J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
[TBL] [Abstract][Full Text] [Related]
16. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
17. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
Pennington JE; Small GJ
J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
[TBL] [Abstract][Full Text] [Related]
18. [Polish preparations for preventing and treating infections caused by Pseudomonas aeruginosa].
Schiller B; Buchowicz I; Lysakowska E; Sakiel S; Korbecki M
Zh Mikrobiol Epidemiol Immunobiol; 1985 Apr; (4):30-2. PubMed ID: 2409720
[TBL] [Abstract][Full Text] [Related]
19. Pseudomonas immunoglobulin and vaccine in burn patients.
Bose B
Lancet; 1981 Feb; 1(8217):435. PubMed ID: 6110056
[No Abstract] [Full Text] [Related]
20. [Protective effect of a corpuscular polyvalent Pseudomonas aeruginosa vaccine in generalized chronic Pseudomonas aeruginosa infection in mice with cyclophosphamide-induced leukopenia].
Vetkova LG; Zaĭtsev LG; Khasman EL; Radkevich SA; Moroz AF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Mar; (3):14-8. PubMed ID: 3085409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
